Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials

By afschroeder • August 13, 2025

Sheppard JP, Lakshmanan S, Palatnic L, Dahal S, Roy SK, Bhatt DL, Budoff MJ, Nelson JR. Effects of purified eicosapentaenoic acid versus mixed eicosapentaenoic/docosahexaenoic acid pharmacotherapies on coronary plaque volume: network meta-analysis of prospective coronary imaging trials. Acta Cardiol. 2025 Aug 12:1-13. doi: 10.1080/00015385.2025.2538404. Epub ahead of print. PMID: 40795199.

Tags: Cardiology/Epi, coronary artery disease, coronary imaging, docosahexaenoic acid, Eicosapentaenoic acid, Harbor UCLA, meta-analysis, Omega-3 fatty acids, Publications

Related Posts

Heart Failure Quality of Care Among Asian Patients in the United States

Huang X, Huffman MD, Kandula NR, Petito LC, Agarwal A, Yancy CW, Fonarow GC, Jhund PS, Mefford MT, Reynolds KL, Khan SS, Shah NS. Heart[...]

Public Reporting of Quality and Clinical Outcomes in the Get With The Guidelines-Stroke Registry

Mullen MT, Zhao J, Jiang T, Gao Z, Buechner J, Wahab F, Seo MH, Harder B, Schwamm LH, Fonarow GC, Smith EE, Xian Y, Messé[...]

Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and altered bile pathway gene expression

Zhao X, Zhou J, Chyu KY, Erbay E, Cercek B, Shah PK, Dimayuga PC. Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and[...]